Rhododendron album Blume extract inhibits TNF-α/IFN-γ-induced chemokine production via blockade of NF-κB and JAK/STAT activation in human epidermal keratinocytes
Rhododendron album Blume (RA) has traditionally been used as an herbal medicine and is considered to have antiinflammatory properties. It is a wellknown medicine for treatment of allergic or atopic diseases. In the present study, the biological effects of an RA methanol extract (RAME)
on inflammation were investigated in tumor necrosis factorα (TNFα)/interferonγ (IFNγ)stimulated human keratinocytes. The present study aimed to investigate the potential mechanisms by which RAME inhibited TNFα/IFNγinduced expression of chemokines [thymus
and activation-regulated chemokine (TARC) and macrophagederived chemokine (MDC)] and cytokines [interleukin (IL)6 and IL8] through the nuclear factorκB (NFκB) pathway in human keratinocytes. The effects of RAME treatment on cell viability were investigated in TNFα/IFNγstimulated
HaCaT cells. The expression of TARC, MDC, IL6 and IL8 was assessed using reverse transcriptionquantitative polymerase chain reaction analysis or ELISA, and its effect on the inhibitory mitogen-activated protein kinase pathway was also studied using western blot analysis. TNFα/IFNγ
induced the expression of IL6, IL8, TARC and MDC in a dosedependent manner through NFκB and Janus kinase/signal transducers and activators of transcription (JAK/STAT) activation. Notably, treatment with RAME significantly suppressed TNF-α/IFN-γ-induced expression of IL6,
IL8, TARC, and MDC. In addition, RAME treatment inhibited the activation of NFκB and the JAK/STAT pathway in TNFα/IFNγinduced HaCaT cells. These results suggest that RAME decreases the production of chemokines and proinflammatory cytokines by suppressing the NFκB and
the JAK/STAT pathways. Consequently, RAME may potentially be used for treatment of atopic dermatitis.
Document Type: Research Article
Affiliations: 1: Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Chungbuk 28116, Republic of Korea 2: International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea 3: Center for Pharmaceutical and Medical Technology, Kawasan Puspiptek Serpong, LAPTIAB, Tangerang, Banten 15314, Indonesia
Publication date: 01 January 2018
- The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.
The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases. - Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content